Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics-Reference-Cited by-同舟云学术

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics

Published:2023-05-11 Issue:8 Volume:38 Page:1918-1920
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Peyro-Saint-Paul Laure¹^ORCID,Bechade Clémence²³^ORCID,Cesbron Alexandre⁴,Debruyne Danièle⁴,Brionne Marie⁵,Brucato Sylvie⁶,Hanoy Mélanie⁷,Dumont Audrey⁸⁹,Briant Anais R¹⁰,Parienti Jean-Jacques¹⁰¹¹,Lobbedez Thierry²³^ORCID,Ficheux Maxence¹²

Affiliation:

1. CHU de Caen Normandie, Department of Clinical Research and Biostatistics , Caen, France

2. Department of Nephrology, Normandie University, UNICAEN, CHU de Caen Normandie, Caen, France

3. ANTICIPE, U1086 INSERM-UCN, Centre François Baclesse , Caen , France

4. CHU de Caen Normandie , Pharmacologie, Caen, France

5. CHU de Caen Normandie , Hématologie Biologique, Caen, France

6. CHU de Caen Normandie , Centre de Recherche Clinique, Caen, France

7. CHU Rouen, Nephrology, Dialysis and Kidney Transplantation , Rouen , France

8. Univ Rouen Normandie, INSERM EnVI U1096, “Endothelium, Valvulopathy and Heart Failure”

9. CHU Rouen, CIC-CRB 1404, Department of Pharmacology , Rouen , France

10. Department of Clinical Research and Biostatistics, CHU de Caen Normandie and Caen Normandy University , Caen, France

11. INSERM U1311 DYNAMICURE, Caen Normandy University , Caen, France

12. CHU de Caen Normandie , Néphrologie, Caen, France

Funder

French Health Ministry

PHRC

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad087/50518181/gfad087.pdf

Reference8 articles.

1. Should oral anticoagulation be used in ESKD patients on hemodialysis with atrial fibrillation?: Commentary;Mavrakanas;Kidney360,2021

2. Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion;De Vriese;Nephrol Dial Transplant,2022

3. Clinical pharmacokinetics in kidney disease;Lea-Henry;Clin J Am Soc Nephrol,2018

4. Apixaban: a clinical pharmacokinetic and pharmacodynamic review;Byon;Clin Pharmacokinet,2019

5. Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis;Wang;J Clin Pharmacol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the geriatric nutritional risk index and clinical outcomes among peritoneal dialysis patients: A meta-analysis;Medicine;2024-05-03

2. The effect of meditative movement for glucose control in patients with type 2 diabetes: A protocol for systematic review and meta-analysis of controlled trails: Erratum;Medicine;2024-05-03

3. Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis;Kidney Medicine;2023-08